NEWLUX Trademark

Trademark Overview


On Monday, May 16, 2022, a trademark application was filed for NEWLUX with the United States Patent and Trademark Office. The USPTO has given the NEWLUX trademark a serial number of 79344067. The federal status of this trademark filing is REGISTERED as of Tuesday, December 26, 2023. This trademark is owned by Medytox Inc.. The NEWLUX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents affecting sensory organs; muscle relaxants; preparations for the treatment of muscle fatigue;pharmaceutical agents affecting peripheral nervous system; vaccines; pharmaceuticals containing botulinum toxin for medical use for use in treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, neuropathy pain and pelvic pain; bacteria poisons;pharmacological preparations for skin care; chemico-pharmaceutical preparations for skin care, skin wounds, prevention of migraines; pharmaceutical agents for epidermis; biological preparations for medical or veterinary purposes being bacterial and bacteriological preparations; medicated lotions for skin, sunburn, face, body; pharmaceutical syringes prefilled with medical botul...
newlux

General Information


Serial Number79344067
Word MarkNEWLUX
Filing DateMonday, May 16, 2022
Status700 - REGISTERED
Status DateTuesday, December 26, 2023
Registration Number7251179
Registration DateTuesday, December 26, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2023

Trademark Statements


Goods and ServicesPharmaceutical agents affecting sensory organs; muscle relaxants; preparations for the treatment of muscle fatigue;pharmaceutical agents affecting peripheral nervous system; vaccines; pharmaceuticals containing botulinum toxin for medical use for use in treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, neuropathy pain and pelvic pain; bacteria poisons;pharmacological preparations for skin care; chemico-pharmaceutical preparations for skin care, skin wounds, prevention of migraines; pharmaceutical agents for epidermis; biological preparations for medical or veterinary purposes being bacterial and bacteriological preparations; medicated lotions for skin, sunburn, face, body; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient; medical infusions for treating migraine headaches, excessive sweating, urinary incontinence; injectable dermal fillers; implantable medicines being medicinal infusions, injectable gels, injectable pharmaceuticals for use in the treatment of anaphylactic reactions, migraine headaches, urinary incontinence, neurological disorders and muscle dystonia; pharmaceutical preparations acting on the central nervous system; pain relief medication; dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders
Pseudo MarkNEW LUX

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMedytox Inc.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressKR

Party NameMedytox Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressKR

Party NameMedytox Inc.
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressKR

Party NameMedytox Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKR

Trademark Events


Event DateEvent Description
Wednesday, March 27, 2024FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 27, 2024FINAL DISPOSITION PROCESSED
Tuesday, March 26, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 2, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, December 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 26, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, December 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, October 10, 2023NOTIFICATION PROCESSED BY IB
Tuesday, October 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 20, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 29, 2023REFUSAL PROCESSED BY IB
Friday, March 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 3, 2023REFUSAL PROCESSED BY MPU
Saturday, January 7, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 6, 2023NON-FINAL ACTION WRITTEN
Wednesday, December 28, 2022ASSIGNED TO EXAMINER
Tuesday, July 12, 2022APPLICATION FILING RECEIPT MAILED
Friday, July 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 7, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB